Ro Review - Regulated Telehealth Pathway Disclosure

Methodology score

Provisional score last reviewed 2026-05-28. Scores are reviewed quarterly and are not influenced by commission rates.

Visit source Methodology

Independent testing

14/30

COA accessibility

6/15

Manufacturing transparency

12/15

Support responsiveness

9/10

Shipping transparency

9/10

Years and community signal

9/10

Pricing transparency

9/10

Relationship status: This is an outreach or candidate listing. PeptideUnicorn does not currently list an active affiliate relationship for this profile. Editorial scores follow the public methodology and are maintained separately from monetization. Official page lists FDA-approved GLP-1 options such as Wegovy and Zepbound; not scored as a research peptide supplier.

Verification status

Ro is listed as a regulated telehealth pathway for prescription-product education. It is not scored as a research peptide vendor. Ro’s public weight-loss page lists access to FDA-approved GLP-1 options such as Wegovy and Zepbound when clinically appropriate.

What we review

Clear clinical pathway disclosure
Prescription and pharmacy framing
Pricing transparency
Support and customer-service signals
Affiliate disclosure

Affiliate disclosure

PeptideUnicorn does not currently show an active affiliate relationship for this profile. Editorial coverage stays separate from any future commission terms.

Summary

This profile helps the quiz and directory distinguish regulated clinical pathways from research-vendor education.